Lumida
/NAGE
⌘K
Niagen Bioscience Inc

Niagen Bioscience Inc

NAGE
$3.28USD-3.53%-0.12 today

MARKET CAP

261.2M

P/E (TTM)

17.3x

FWD P/E

11.7x

DAY RANGE

$3 – $3

52W RANGE

$3
$12

AI Summary

Stalk
Sell NowHigh

Given the decisive break below the 3.61 support with elevated volume and extended EMAs, the downtrend remains intact across all horizons. Long-term and medium-term biases are bearish. Short-term conditions favor execution now. We will sell into the breakdown, leveraging momentum continuation dynamics.

  • Q1’26 revenue $31.5M (+5% YoY); 2026 growth guidance 10–15%.
  • Cash $66.5M, zero debt supports R&D and market expansion.
  • FDA ruling on NMN opens flood of competitors, threatens margins.
Full analysis →
Insider Trades6 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 30, 2026BuyNAGERobert N FriedChief Executive Officer1,106$2.71$261.2M-71.68%+3.31%$3.0K+0.10%16bSell Now
Jun 30, 2026BuyNAGECarlos Luis LopezSVP, General Counsel2,314$2.71$261.2M-71.68%+3.31%$6.3K+102.80%16bSell Now
Jun 30, 2026BuyNAGEOzan PamirChief Financial Officer4,255$2.71$261.2M-71.68%+3.31%$11.5K+57.72%16bSell Now
Apr 24, 2026BuyNAGERobert N FriedChief Executive Officer20,000$2.61$261.2M-71.68%+3.31%$52.2K+1.92%Sell Now
Nov 14, 2025BuyNAGEOzan PamirChief Financial Officer6,685.405$6.82$261.2M-71.68%+3.31%$45.6K+229.96%Sell Now
Apr 9, 2025BuyNAGERobert N FriedChief Executive Officer66,667$3.30$261.2M-71.68%+3.31%$220.0K+6.86%Sell Now